Only low-potency and least-potency steroid creams should be used on the face. Facial skin is significantly thinner than skin on the rest of your body, which means it absorbs topical steroids at a much higher rate and is far more vulnerable to side effects. The safest options fall into potency groups VI and VII on the standard seven-tier classification system, and some are available over the counter.
Why the Face Needs a Milder Steroid
Skin thickness varies dramatically across the body. Your forearms, trunk, and legs have a relatively thick outer barrier, but facial skin is much thinner, especially around the eyelids and lips. Research on percutaneous absorption shows that using forearm penetration data alone underestimates total body exposure by at least a factor of two, and the face absorbs even more than most other sites. That higher absorption rate is exactly why a steroid that’s perfectly safe on your elbows can cause real damage on your cheeks or forehead.
The American Academy of Family Physicians states plainly that high- and ultra-high-potency steroids should not be used on the face, groin, or underarms except in rare situations and for very short durations. Low-potency steroids are the safest agents for these areas, for large surface areas, for long-term use, and for children.
Specific Steroid Creams Safe for the Face
Topical corticosteroids are ranked into seven potency groups, with group I being the strongest and group VII the mildest. For facial skin, groups VI and VII are recommended:
- Hydrocortisone 1% or 2.5% (Group VII, least potent): Hydrocortisone 1% is the most accessible option and is available without a prescription. It was approved for over-the-counter sale in the late 1980s after the FDA determined it was safe and effective for general anti-itch use. The 2.5% strength typically requires a prescription.
- Desonide 0.05% (Group VI): A commonly prescribed low-potency steroid frequently used for facial eczema and mild dermatitis. Prescription only.
- Alclometasone dipropionate 0.05% (Group VI): Another prescription low-potency option suitable for sensitive areas including the face.
- Fluocinolone 0.01% (Group VI): Used in low concentration for facial conditions. Prescription only.
- Hydrocortisone butyrate 0.1% (Group VI): Slightly more potent than plain hydrocortisone but still in the low-potency range considered appropriate for facial use. Prescription only.
If you’re looking for something you can buy today without seeing a doctor, hydrocortisone 1% cream is your only real option. It’s widely available at pharmacies. However, the labeling on most over-the-counter hydrocortisone products actually advises against facial application without physician guidance. If your skin condition is more than a brief, mild irritation, a prescription-strength low-potency steroid from your dermatologist will generally work better and be used under proper supervision.
Conditions That Call for Facial Steroids
Low-potency topical steroids are indicated for a range of inflammatory skin conditions that commonly affect the face. These include atopic dermatitis (eczema), contact dermatitis, eyelid dermatitis, seborrheic dermatitis, and mild psoriasis in limited areas. The American Academy of Dermatology recommends topical corticosteroids as a core treatment for adults with atopic dermatitis, and for facial flares, the standard approach is to use the lowest effective potency.
For conditions like lichen planus, discoid lupus, or more severe psoriasis, a doctor may occasionally use a medium-potency steroid on facial skin for a very short course, but this is the exception rather than the rule.
How Long You Can Safely Apply Them
Duration matters as much as potency. Clinical guidelines note that there is no specified time limit for low-potency topical corticosteroid use, which sets them apart from stronger formulations that carry strict time caps (three weeks maximum for the most potent products, up to 12 weeks for medium-strength ones). That said, “no specified limit” doesn’t mean indefinite unsupervised use. Even mild steroids can cause problems on the face over many weeks or months of continuous application. Most dermatologists recommend using them until the flare resolves, then stopping or switching to a non-steroidal maintenance option.
Application frequency is typically once or twice daily, and a thin layer is all that’s needed. More product doesn’t mean faster results. It just increases absorption and side-effect risk.
What Happens When Stronger Steroids Are Used on the Face
Misusing potent steroids on the face, or using even mild ones for too long, produces a well-documented set of problems. Repeated application causes the outer skin layer to thin, and the connective tissue underneath begins to break down. The result is skin that looks lax, shiny, transparent, and wrinkled, with visible veins underneath. Dermatologists call the full picture “topical steroid damaged facies,” and it can include several overlapping problems.
Skin thinning (atrophy) is the most common issue. Tiny blood vessels become permanently dilated and visible on the surface, a condition called telangiectasia. Stretch marks can appear. Perioral dermatitis, a rash of small follicular bumps and pustules around the mouth, develops primarily in women who have used potent steroids on their face long-term. It spares a small ring of skin right next to the lip border, which is one way to identify it.
Steroid-induced rosacea is another frequent consequence, particularly linked to fluorinated steroids. It produces a bright red, scaly, papule-covered appearance sometimes described as “red face syndrome.” The mechanism involves rebound dilation of blood vessels and inflammatory signaling triggered by chronic, repeated steroid exposure. Critically, many people who develop these problems keep using the steroid because their skin flares when they stop, creating a cycle of dependence that can be difficult to break without medical help.
Applying steroids near the eyes carries additional risk. Prolonged use of corticosteroids around the eyelids has been associated with increased pressure inside the eye, which can contribute to glaucoma over time.
Non-Steroidal Alternatives for Facial Skin
If you need long-term treatment for a chronic condition like eczema on your face, non-steroidal options may be a better fit. Two main categories are available by prescription.
Calcineurin inhibitors, specifically tacrolimus and pimecrolimus, work through a different anti-inflammatory pathway than steroids. They’re approved for adults and children over two years old with atopic dermatitis. The key advantage for facial use is that tacrolimus does not cause skin thinning or the systemic effects associated with steroids. Clinical trials have demonstrated its safety for up to four years of use, making it a strong option for people who need ongoing treatment on sensitive areas.
A newer option is crisaborole, a phosphodiesterase-4 inhibitor approved for mild to moderate atopic dermatitis. It has minimal systemic absorption, no risk of skin thinning or atrophy, and has been specifically studied on thin, sensitive skin areas including the face and groin. Because topical steroids are limited by side effects in exactly these areas, crisaborole fills an important gap for patients who need something safe for delicate skin over the long term.
Both calcineurin inhibitors and crisaborole are currently considered second-line treatments, meaning doctors typically try a short course of low-potency steroids first and switch to these alternatives for ongoing maintenance or for patients who don’t tolerate steroids well.